Related Experiment Video
Updated: May 15, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Blood and body fluid exposures: consent for source patient testing
1Sheffield Occupational Health Service, Northern General Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Silverwood S5 7AU, UK. prosenjitgiri@hotmail.com
Routine testing of source patients after blood and body fluid (BBF) exposure is not universal in healthcare settings. Incapacity to consent and unrecorded reasons hinder source patient testing, necessitating further investigation.
Area of Science:
- Occupational Health
- Infectious Disease Prevention
- Healthcare Safety
Background:
- Blood and body fluid (BBF) exposure poses significant occupational risks to healthcare workers.
- UK guidelines recommend routine source patient testing for blood-borne viruses post-exposure.
- Barriers to source patient testing, including consent and procedural compliance, require further understanding.
Purpose of the Study:
- To determine the frequency of serological testing in identified source patients following BBF exposure.
- To identify the reasons why source patients are not tested, including consent issues and refusals.
Main Methods:
- A retrospective review of BBF exposure incidents reported to Sheffield Occupational Health Service from January 1, 2009, to December 31, 2009.
- Analysis of source patient identification and testing rates across different healthcare staff groups.
Main Results:
- Source patients were identified in 87% of 490 reported BBF exposure incidents.
- Source patient serological testing occurred in 56% of incidents.
- Testing rates varied significantly by staff type: medical (76%) and nursing (69%) staff had higher rates than non-clinical (36%) and dental (17%) staff.
- For 151 identified source patients not tested, reasons were unrecorded in 66%, incapacity to consent in 20%, and refusal in 5%.
Conclusions:
- Despite recommendations, routine source patient testing for BBF exposure is not consistently implemented.
- Incapacity to provide consent is a notable factor contributing to the lack of source patient testing.
- Further research is needed to explore other barriers to testing and inform policy development.
More Related Videos
11:28Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bioavailability Study Design: Healthy Subjects Versus Patients
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...